True Vision MN LLC: XLC position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of True Vision MN LLC on XLC, newest first. How the timeline and the estimate are built.
True Vision MN LLC held 6,098 XLC shares at 2026-03-31 per its 13F-HR filed 2026-04-16.
the latest 13F is the newest step
- period ended2026-03-3113F 6,098 sharesChange vs previous 13F +837 shares
0.35% of the 13F portfolio, value $676,024.
13F-HR 0001951757-26-000625 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 5,261 sharesChange vs previous 13F +78 shares
0.31% of the 13F portfolio, value $619,325.
13F-HR 0001951757-26-000079 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 5,183 sharesChange vs previous 13F +1,539 shares
0.32% of the 13F portfolio, value $613,512.
13F-HR 0001951757-25-001201 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,644 sharesChange vs previous 13F -111 shares
0.22% of the 13F portfolio, value $395,483.
13F-HR 0001951757-25-000933 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,755 sharesChange vs previous 13F -4,028 shares
0.22% of the 13F portfolio, value $362,170.
13F-HR 0001951757-25-000484 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 7,783 sharesChange vs previous 13F not available
0.45% of the 13F portfolio, value $753,472.
13F-HR 0001951757-25-000151 filed by True Vision MN LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).